143 related articles for article (PubMed ID: 12718539)
21. Substrate specificity of Pasteurella multocida toxin for α subunits of heterotrimeric G proteins.
Orth JH; Fester I; Siegert P; Weise M; Lanner U; Kamitani S; Tachibana T; Wilson BA; Schlosser A; Horiguchi Y; Aktories K
FASEB J; 2013 Feb; 27(2):832-42. PubMed ID: 23150526
[TBL] [Abstract][Full Text] [Related]
22. Action of Pasteurella multocida toxin depends on the helical domain of Galphaq.
Orth JH; Lang S; Aktories K
J Biol Chem; 2004 Aug; 279(33):34150-5. PubMed ID: 15192096
[TBL] [Abstract][Full Text] [Related]
23. Localization of functional domains of the mitogenic toxin of Pasteurella multocida.
Pullinger GD; Sowdhamini R; Lax AJ
Infect Immun; 2001 Dec; 69(12):7839-50. PubMed ID: 11705966
[TBL] [Abstract][Full Text] [Related]
24. Auranofin Inhibits the Enzyme Activity of Pasteurella multocida Toxin PMT in Human Cells and Protects Cells from Intoxication.
Carle S; Brink T; Orth JH; Aktories K; Barth H
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28098782
[TBL] [Abstract][Full Text] [Related]
25. Pasteurella multocida toxin: Targeting mast cell secretory granules during kiss-and-run secretion.
Danielsen EM; Christiansen N; Danielsen EM
Tissue Cell; 2016 Feb; 48(1):1-9. PubMed ID: 26763205
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic actions of Pasteurella multocida toxin detected by monoclonal antibodies recognizing the deamidated α subunit of the heterotrimeric GTPase Gq.
Kamitani S; Ao S; Toshima H; Tachibana T; Hashimoto M; Kitadokoro K; Fukui-Miyazaki A; Abe H; Horiguchi Y
FEBS J; 2011 Aug; 278(15):2702-12. PubMed ID: 21624053
[TBL] [Abstract][Full Text] [Related]
27. Effect of Pasteurella multocida toxin on physeal growth in young pigs.
Ackermann MR; Register KB; Stabel JR; Gwaltney SM; Howe TS; Rimler RB
Am J Vet Res; 1996 Jun; 57(6):848-52. PubMed ID: 8725812
[TBL] [Abstract][Full Text] [Related]
28. Crystallization and preliminary crystallographic studies of the Pasteurella multocida toxin catalytic domain.
Miyazawa M; Kitadokoro K; Kamitani S; Shime H; Horiguchi Y
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Sep; 62(Pt 9):906-8. PubMed ID: 16946476
[TBL] [Abstract][Full Text] [Related]
29. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
Kim TJ; Lee JI; Lee BJ
J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the membrane-targeting C1 domain in Pasteurella multocida toxin.
Kamitani S; Kitadokoro K; Miyazawa M; Toshima H; Fukui A; Abe H; Miyake M; Horiguchi Y
J Biol Chem; 2010 Aug; 285(33):25467-75. PubMed ID: 20534589
[TBL] [Abstract][Full Text] [Related]
31. Pasteurella multocida toxin is a potent inducer of anchorage-independent cell growth.
Higgins TE; Murphy AC; Staddon JM; Lax AJ; Rozengurt E
Proc Natl Acad Sci U S A; 1992 May; 89(10):4240-4. PubMed ID: 1584759
[TBL] [Abstract][Full Text] [Related]
32. Detection by in-situ hybridization of Pasteurella multocida toxin (toxA) gene in the lungs of naturally infected pigs.
Ahn KK; Lee YH; Ha Y; Kim D; Chae S; Kim CH; Lee JH; Kim SH; Chae C
J Comp Pathol; 2008 Jul; 139(1):51-3. PubMed ID: 18495148
[TBL] [Abstract][Full Text] [Related]
33. Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin.
Wilson BA; Aminova LR; Ponferrada VG; Ho M
Infect Immun; 2000 Aug; 68(8):4531-8. PubMed ID: 10899852
[TBL] [Abstract][Full Text] [Related]
34. Binding residues and catalytic domain of soluble Saccharomyces cerevisiae processing alpha-glucosidase I.
Faridmoayer A; Scaman CH
Glycobiology; 2005 Dec; 15(12):1341-8. PubMed ID: 16014748
[TBL] [Abstract][Full Text] [Related]
35. Biological activity of a C-terminal fragment of Pasteurella multocida toxin.
Busch C; Orth J; Djouder N; Aktories K
Infect Immun; 2001 Jun; 69(6):3628-34. PubMed ID: 11349023
[TBL] [Abstract][Full Text] [Related]
36. Mutational analysis of Ca(2+)/calmodulin-dependent protein kinase phosphatase (CaMKP).
Tada Y; Nimura T; Sueyoshi N; Ishida A; Shigeri Y; Kameshita I
Arch Biochem Biophys; 2006 Aug; 452(2):174-85. PubMed ID: 16844074
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the two active sites of the hyaluronan synthase and the chondroitin synthase of Pasteurella multocida.
Jing W; DeAngelis PL
Glycobiology; 2003 Oct; 13(10):661-71. PubMed ID: 12799342
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of the Pasteurella multocida toxin translocation domain.
Baldwin MR; Lakey JH; Lax AJ
Mol Microbiol; 2004 Oct; 54(1):239-50. PubMed ID: 15458419
[TBL] [Abstract][Full Text] [Related]
39. Membrane interaction of Pasteurella multocida toxin involves sphingomyelin.
Brothers MC; Ho M; Maharjan R; Clemons NC; Bannai Y; Waites MA; Faulkner MJ; Kuhlenschmidt TB; Kuhlenschmidt MS; Blanke SR; Rienstra CM; Wilson BA
FEBS J; 2011 Dec; 278(23):4633-48. PubMed ID: 21951695
[TBL] [Abstract][Full Text] [Related]
40. Immune response in mice and swine to DNA vaccines derived from the Pasteurella multocida toxin gene.
Register KB; Sacco RE; Brockmeier SL
Vaccine; 2007 Aug; 25(32):6118-28. PubMed ID: 17590484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
